Article Versions Notes

Nguyen-Dumont T, Dowty JG, MacInnis RJ, Steen JA, Riaz M, Dugué P-A, Renault A-L, Hammet F, Mahmoodi M, Theys D, et al. Rare Germline Pathogenic Variants Identified by Multigene Panel Testing and the Risk of Aggressive Prostate Cancer. Cancers. 2021; 13(7):1495. https://doi.org/10.3390/cancers13071495

Nguyen-Dumont, Tú, James G. Dowty, Robert J. MacInnis, Jason A. Steen, Moeen Riaz, Pierre-Antoine Dugué, Anne-Laure Renault, Fleur Hammet, Maryam Mahmoodi, Derrick Theys, and et al. 2021. "Rare Germline Pathogenic Variants Identified by Multigene Panel Testing and the Risk of Aggressive Prostate Cancer" Cancers 13, no. 7: 1495. https://doi.org/10.3390/cancers13071495

Nguyen-Dumont, T., Dowty, J. G., MacInnis, R. J., Steen, J. A., Riaz, M., Dugué, P.-A., Renault, A.-L., Hammet, F., Mahmoodi, M., Theys, D., Tsimiklis, H., Severi, G., Bolton, D., Lacaze, P., Sebra, R., Schadt, E., McNeil, J., Giles, G. G., Milne, R. L., & Southey, M. C. (2021). Rare Germline Pathogenic Variants Identified by Multigene Panel Testing and the Risk of Aggressive Prostate Cancer. Cancers, 13(7), 1495. https://doi.org/10.3390/cancers13071495